The evaluation of drug-induced mitochondrial impairment may be important in drug development as well as in the comprehension of molecular mechanisms of the therapeutic and adverse effects of drugs. The primary aim of this study was to investigate the effects of four drugs for treatment of depression (bupropion, fluoxetine, amitriptyline, and imipramine) and five drugs for bipolar disorder treatment (lithium, valproate, valpromide, lamotrigine, and carbamazepine) on cell energy metabolism. The in vitro effects of the selected psychopharmaca were measured in isolated pig brain mitochondria; the activities of citrate synthase (CS) and electron transport chain (ETC) complexes (I, II + III, and IV) and mitochondrial respiration rates linked to complex I and complex II were measured. Complex I was significantly inhibited by lithium, carbamazepine, fluoxetine, amitriptyline, and imipramine. The activity of complex IV was decreased after exposure to carbamazepine. The activities of complex II + III and CS were not affected by any tested drug. Complex I-linked respiration was significantly inhibited by bupropion, fluoxetine, amitriptyline, imipramine, valpromide, carbamazepine, and lamotrigine. Significant inhibition of complex II-linked respiration was observed after mitochondria were exposed to amitriptyline, fluoxetine, and carbamazepine. Our outcomes confirm the need to investigate the effects of drugs on both the total respiration rate and the activities of individual enzymes of the ETC to reveal the risk of adverse effects as well as to understand the molecular mechanisms leading to drug-induced changes in the respiratory rate. Our approach can be further replicated to study the mechanisms of action of newly developed drugs.

Department of Psychiatry 1st Faculty of Medicine Charles University and General University Hospital Prague Ke Karlovu 11 120 00 Prague 2 Czech Republic

Institute of Pharmacology 1st Faculty of Medicine Charles University and General University Hospital Prague Albertov 4 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

Toxicol Lett. 2012 Sep 18;213(3):345-52 PubMed

Arch Gen Psychiatry. 2004 Mar;61(3):300-8 PubMed

Biol Psychiatry. 2006 Jun 1;59(11):1006-20 PubMed

Brain Res Bull. 2007 Mar 30;71(6):633-40 PubMed

J Clin Psychiatry. 1995 Sep;56(9):395-401 PubMed

Neuro Endocrinol Lett. 2010;31(3):336-42 PubMed

Cell Calcium. 2008 Jul;44(1):92-102 PubMed

Eur J Pharmacol. 2006 Jun 6;539(1-2):18-26 PubMed

Bipolar Disord. 2003 Dec;5(6):421-33 PubMed

Neurosci Lett. 2011 Jan 10;487(3):278-81 PubMed

Toxicology. 2011 Jul 11;285(1-2):1-7 PubMed

J Clin Psychiatry. 2006 Jul;67(7):1034-41 PubMed

Bipolar Disord. 2009 Aug;11(5):515-22 PubMed

Arch Intern Med. 2001 Feb 26;161(4):612 PubMed

Curr Opin Pharmacol. 2004 Feb;4(1):58-64 PubMed

Drug News Perspect. 2006 Dec;19(10):597-602 PubMed

Proc Natl Acad Sci U S A. 1989 Apr;86(7):2379-82 PubMed

Genomics. 2004 Dec;84(6):1041-50 PubMed

Biochem Pharmacol. 2010 Mar 1;79(5):792-9 PubMed

Toxicol Lett. 2016 Sep 6;258:185-191 PubMed

Acta Neuropsychiatr. 2011 Dec;23(6):282-91 PubMed

Curr Opin Psychiatry. 2013 Jan;26(1):60-5 PubMed

Neurochem Int. 2010 Feb;56(3):394-403 PubMed

Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1209-1223 PubMed

Circulation. 2006 Apr 11;113(14):1807-16 PubMed

Psychosomatics. 2004 Sep-Oct;45(5):371-7 PubMed

Mol Psychiatry. 2005 Jan;10(1):105-16 PubMed

Acta Psychiatr Scand. 2010 Jul;122(1):30-9 PubMed

Expert Opin Drug Metab Toxicol. 2012 Jan;8(1):71-9 PubMed

Toxicol Mech Methods. 2013 Oct;23(8):617-23 PubMed

Psychopharmacology (Berl). 1999 Feb;141(4):370-7 PubMed

Cochrane Database Syst Rev. 2003;(1):CD004052 PubMed

Biochem Soc Trans. 1991 Aug;19(3):253S PubMed

Circ Res. 2014 Jun 20;115(1):44-54 PubMed

Presse Med. 2000 Feb 19;29(6):306-7 PubMed

Hum Mol Genet. 2005 Jan 15;14(2):241-53 PubMed

Neurochem Res. 2011 Feb;36(2):327-38 PubMed

Mol Psychiatry. 2005 Oct;10(10):900-19 PubMed

Bipolar Disord. 2007 Jun;9 Suppl 1:119-27 PubMed

Psychopharmacology (Berl). 2015 Jan;232(1):245-50 PubMed

CNS Neurosci Ther. 2011 Dec;17(6):649-60 PubMed

Clin Chim Acta. 1994 Jul;228(1):35-51 PubMed

Int J Cardiol. 2005 May 11;101(1):147-50 PubMed

Bipolar Disord. 2000 Dec;2(4):336-9 PubMed

Acta Psychiatr Scand. 2012 Nov;126(5):332-41 PubMed

Circulation. 1995 Feb 15;91(4):955-61 PubMed

Neuropsychopharmacology. 2000 Apr;22(4):346-56 PubMed

Mol Psychiatry. 2006 Mar;11(3):241-51 PubMed

Methods Enzymol. 1996;264:484-509 PubMed

Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:19-26 PubMed

Psychiatry Res. 2018 Jun;264:192-201 PubMed

Biol Psychiatry. 2003 Nov 15;54(10):1049-59 PubMed

Drug Res (Stuttg). 2017 Apr;67(4):217-222 PubMed

Pediatr Res. 2007 Jul;62(1):14-9 PubMed

Int J Neuropsychopharmacol. 2014 Oct 31;18(6): PubMed

Biochem Pharmacol. 1986 May 1;35(9):1445-51 PubMed

J Affect Disord. 2001 Feb;62(3):151-64 PubMed

CNS Neurol Disord Drug Targets. 2017;16(2):176-186 PubMed

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):494-502 PubMed

Am J Pathol. 2010 Aug;177(2):575-85 PubMed

Brain Res Bull. 1997;43(4):393-403 PubMed

J Clin Psychiatry. 1993 Sep;54 Suppl:35-41; discussion 55-6 PubMed

J Neurosci. 2008 Aug 6;28(32):8040-52 PubMed

Biochem Pharmacol. 1992 Jun 9;43(11):2435-42 PubMed

Neuro Endocrinol Lett. 2010;31(5):645-56 PubMed

J Child Neurol. 2010 May;25(5):541-5 PubMed

Toxicol In Vitro. 2008 Aug;22(5):1143-52 PubMed

J Inherit Metab Dis. 2008 Apr;31(2):205-16 PubMed

Methods Mol Biol. 2012;810:25-58 PubMed

Circ Res. 2008 Feb 29;102(4):401-14 PubMed

Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity

Effect of Novel Antipsychotics on Energy Metabolism - In Vitro Study in Pig Brain Mitochondria